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Short Report
FOXL2 is a single-exon gene encoding a forkhead transcription factor 1 expressed in the ovarian somatic compartment and peri-ocular tissues 2 . In humans, its mutations cause the Blepharophimosis-Ptosis-Epicanthus inversus Syndrome (BPES), which involves craniofacial/palpebral abnormalities associated or not with premature ovarian failure (POF) 3 .
Here, we study the effects of a To assess the potential deleterious effect of the amino acid change we used the SIFT software (http://blocks.fhcrc.org/sift/SIFT.html). SIFT uses protein sequence conservation data to calculate the probability of a substitution of being deleterious. Scores lower than 0.05 suggest a potential pathogenicity. The score of p.Gly187Asp, obtained using the alignment shown in Figure 1 , was 0.
The substitution p.Gly187Asp implies an important change in polarity. Glycine is a small neutral amino acid whereas aspartate is acidic and negatively charged at pH 7. Interestingly, Tyr186 is predicted to be phosphorylatable (http://www.cbs.dtu.dk/services/NetPhosK/). Therefore, we hypothesize that the negative charge of the side chain of aspartate might interfere with the posttranslational modification process or mimic the modification itself, perturbing ovarian-specific protein interactions and/or regulations.
To assess subcellular localization and transcriptional activity of FOXL2-G187D, we performed transfection experiments and luciferase reporter assays as previously described 5, 6 . The though significantly less strongly than the normal protein. The p.Ile84Ser mutant, responsible for a type I BPES 7 , was used as a negative control and was, as expected, unable to transactivate our luciferase reporters. We have recently suggested that a positive feedback loop of FOXL2 (which activates its own promoter) might be important in response to oxidative stress in the ovary 8 . Thus, we hypothesize that a lowered transactivation capacity of FOXL2-G187D on ovarian targets might explain the ovarian phenotype in our patient (Figure 2 A, B) . However, the effects of this variant is expected to be promoter-dependent, as previously shown for other mutants 5, 6 , and as shown below for the third reporter promoter that we tested.
We have previously suggested that, in the craniofacial region, the encoding odd-skipped related 2
transcription factor (OSR2) should be a crucial target of FOXL2 9 . Osr2 is, as Foxl2, highly expressed in the murine periocular mesenchyma 10, 11 . Moreover, as described for Foxl2 -/mice,
Osr2 -/mutant neonates exhibit open eyelids with similar abnormalities 10, 11 . Unfortunately, no data concerning the Osr2 -/ovary are available yet 10, 12 . In agreement with our hypothesis and with the absence of an eyelid phenotype in our patient (and in her mutation-carrier father), we found that FOXL2-G187D was able to strongly activate a reporter construct driven by the Osr2 promoter The fact that FOXL2-G187D may be either normal or hypomorph suggests that it can behave as a susceptibility variant whose activity might be shifted up or down by modifier genes, leading to normal ovarian function or POF, respectively. Given our functional evidence, it would be interesting to formally assess the association between p.Gly187Asp and POF.
A previous mutation screening has detected a 30 bp deletion removing 10 out of 14 alanines of the FOXL2 polyAlanine tract (i.e. FOXL2-Ala4) and the substitution p.Tyr258Asn in two POF patients 13, 14 . Interestingly, neither mutation was identified in 200 control chromosomes.
However, the fact that the p.Tyr258Asn variant was maternally inherited and that the patient carrying the FOXL2-Ala4 variant spontaneously conceived and delivered two babies did not allow a formal causal implication of these alterations in absence of functional assays at the time of these studies. Both variants might display incomplete penetrance or lead, at least, to partial fertility recovery after appropriate treatments. Thus, it would be interesting to assess the functional impact for both alterations.
Taken together, our results provide functional evidence in favor of the implication of FOXL2 variants in non-syndromic POF and confirm the regulatory interaction between FOXL2 and OSR2, whose perturbation might contribute to the palpebral phenotype in BPES. In our opinion, a more systematic genetic screening of FOXL2 mutations is of interest in non-syndromic POF, to improve genetic counseling and to better understand the molecular etiology of this frequent pathology. ANOVAs were significant (p<0.001). Post-hoc Tuckey HSD tests showed that the mutant p.Ile84Ser always behaved no differently than the empty control vector, while G187D had a significant activity, through lower than the wild-type/WT protein for 2xFLRE-luc and pFOLX2luc (A,B). Interestingly, in the case of pOsr2-luc (C), G187D had an activity even stronger than the WT. In all cases, p-values were at least < 0.05.
